Community Update – Capsida Clinical Trial

Written By Russ Novy

Dear STXBP1 Community, 

We are sharing a letter to the STXBP1 Community from Capsida, providing an update on the CAP-002 SYNRGY clinical trial.

Our foundation remains committed to transparency. Our contact with Capsida, the study sponsor, and investigators will continue as the investigation proceeds and we will keep sharing verified updates.

Regards, 

The STXBP1 Foundation Team

Below is an update letter to the STXBP1 Community from Capsida 


Russ Novy
Next

Rare development disorder hasn’t kept Wellesley swimmer from varsity